Fluarix Clears FDA; GSK Buys Vaccine Manufacturing Plant From Wyeth
Executive Summary
GlaxoSmithKline is expanding its vaccine manufacturing capability as it prepares for its flu vaccine Fluarix to enter the U.S. market and in anticipation of several vaccine approvals over the next few years
You may also be interested in...
Accelerated Approval Gives Wings To Pandemic Flu Vaccine Development
FDA has unveiled a strategy for preventing influenza vaccine shortages and getting a jump on flu pandemics by using surrogate endpoints to accelerate approval of new vaccines
Accelerated Approval Gives Wings To Pandemic Flu Vaccine Development
FDA has unveiled a strategy for preventing influenza vaccine shortages and getting a jump on flu pandemics by using surrogate endpoints to accelerate approval of new vaccines
Nursing Homes Must Provide Flu Vaccine To Receive Benefits – CMS
Long-term care facilities must provide flu vaccines to residents in order to continue receiving Medicare and Medicaid benefits, CMS says